+検索条件
-Structure paper
タイトル | Mosaic RBD nanoparticle elicits immunodominant antibody responses across sarbecoviruses. |
---|---|
ジャーナル・号・ページ | Cell Rep, Vol. 43, Issue 5, Page 114235, Year 2024 |
掲載日 | 2024年5月28日 |
著者 | Chuanyu Liu / Senyu Xu / Yuxuan Zheng / Yufeng Xie / Kun Xu / Yan Chai / Tingrong Luo / Lianpan Dai / George F Gao / |
PubMed 要旨 | Nanoparticle vaccines displaying mosaic receptor-binding domains (RBDs) or spike (S) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or other sarbecoviruses are used in ...Nanoparticle vaccines displaying mosaic receptor-binding domains (RBDs) or spike (S) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or other sarbecoviruses are used in preparedness against potential zoonotic outbreaks. Here, we describe a self-assembling nanoparticle using lumazine synthase (LuS) as the scaffold to display RBDs from different sarbecoviruses. Mosaic nanoparticles induce sarbecovirus cross-neutralizing antibodies comparable to a nanoparticle cocktail. We find mosaic nanoparticles elicit a B cell receptor repertoire using an immunodominant germline gene pair of IGHV14-3:IGKV14-111. Most of the tested IGHV14-3:IGKV14-111 monoclonal antibodies (mAbs) are broadly cross-reactive to clade 1a, 1b, and 3 sarbecoviruses. Using mAb competition and cryo-electron microscopy, we determine that a representative IGHV14-3:IGKV14-111 mAb, M2-7, binds to a conserved epitope on the RBD, largely overlapping with the pan-sarbecovirus mAb S2H97. This suggests mosaic nanoparticles expand B cell recognition of the common epitopes shared by different clades of sarbecoviruses. These results provide immunological insights into the cross-reactive responses elicited by mosaic nanoparticles against sarbecoviruses. |
リンク | Cell Rep / PubMed:38748880 |
手法 | EM (単粒子) |
解像度 | 3.03 Å |
構造データ | EMDB-38763, PDB-8xxw: |
化合物 | ChemComp-ZN: ChemComp-NAG: |
由来 |
|
キーワード | ANTIVIRAL PROTEIN/IMMUNE SYSTEM / antibody viral protein complex / IMMUNE SYSTEM/VIRAL PROTEIN / ANTIVIRAL PROTEIN / ANTIVIRAL PROTEIN-IMMUNE SYSTEM complex |